HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fernando Perez-Ruiz Selected Research

Uric Acid (Urate)

1/2022One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study.
12/2020High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who's to Blame?
11/2020Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial.
1/2020Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locus.
1/20202018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout.
11/2019Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout.
11/2019Gout.
1/2019Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study.
1/2019Gout.
1/2019Gout, Hyperuricemia, and Crystal-Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fernando Perez-Ruiz Research Topics

Disease

52Gout
01/2022 - 08/2002
9Inflammation (Inflammations)
12/2017 - 01/2009
7Hyperuricemia
12/2016 - 01/2008
5Pain (Aches)
01/2022 - 10/2009
5Gouty Arthritis
11/2019 - 10/2006
3Hyperlipidemias (Hyperlipidemia)
12/2020 - 09/2015
3Hypertension (High Blood Pressure)
12/2020 - 09/2015
3Rheumatic Diseases (Rheumatism)
12/2016 - 10/2015
2Lithiasis
03/2019 - 09/2010
2Renal Insufficiency (Renal Failure)
03/2019 - 06/2016
2Chronic Disease (Chronic Diseases)
01/2019 - 01/2018
2Chronic Renal Insufficiency
12/2017 - 01/2016
2Rheumatoid Arthritis
10/2017 - 08/2003
1Crystal Arthropathies
10/2022
1Acute Coronary Syndrome
11/2020
1Cardiovascular Diseases (Cardiovascular Disease)
11/2020
1Myocardial Infarction
11/2020
1Stroke (Strokes)
11/2020
1Dementia (Dementias)
01/2018
1Acute Kidney Injury (Acute Renal Failure)
12/2017
1Nasopharyngitis
06/2016
1Headache (Headaches)
06/2016
1Arthralgia (Joint Pain)
06/2016
1Urinary Bladder Neoplasms (Bladder Cancer)
03/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2016
1Kidney Diseases (Kidney Disease)
03/2016
1Malnutrition (Nutritional Deficiencies)
12/2015
1Growth Disorders
12/2015
1Thyroid Diseases (Thyroid Disease)
11/2015
1Mobility Limitation (Difficulty Walking)
09/2015
1Cysts
09/2015
1Insulin Resistance
09/2015
1Erythema
09/2015
1Neoplasms (Cancer)
12/2012
1Arthritis (Polyarthritis)
11/2012
1Weight Loss (Weight Reduction)
12/2011
1Low Back Pain (Lumbago)
12/2010
1Renal Colic
09/2010

Drug/Important Bio-Agent (IBA)

51Uric Acid (Urate)IBA
01/2022 - 08/2002
8Allopurinol (Remid)FDA LinkGeneric
01/2022 - 09/2010
8FebuxostatFDA Link
11/2020 - 06/2009
6ColchicineFDA LinkGeneric
01/2022 - 06/2009
5lesinuradIBA
03/2019 - 06/2016
5Xanthine OxidaseIBA
01/2019 - 08/2010
3CreatinineIBA
01/2020 - 06/2016
3Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2019 - 06/2009
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019 - 06/2009
3Pharmaceutical PreparationsIBA
12/2018 - 11/2012
3DiureticsIBA
12/2017 - 12/2011
3SugarsIBA
01/2017 - 03/2016
3PegloticaseFDA Link
11/2012 - 01/2008
2Calcium PyrophosphateIBA
10/2022 - 03/2007
2Biomarkers (Surrogate Marker)IBA
11/2020 - 01/2016
2Xanthine DehydrogenaseIBA
11/2015 - 03/2015
2Adrenocorticotropic Hormone (ACTH)FDA Link
05/2013 - 06/2009
1InflammasomesIBA
01/2019
12-(2,6-dioxopiperidin-3-yl)phthalimidine (EM 12)IBA
01/2019
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2019
1BenzbromaroneIBA
12/2018
1Probenecid (Benemid)FDA LinkGeneric
12/2018
1dimemorfan (AT 17)IBA
01/2018
1Ethanol (Ethyl Alcohol)IBA
12/2017
1Biosimilar PharmaceuticalsIBA
10/2017
1Methotrexate (Mexate)FDA LinkGeneric
10/2017
1Adalimumab (Humira)FDA Link
10/2017
1ABP 501IBA
10/2017
1antineoplaston A10 (A 10)IBA
01/2016
1SmokeIBA
12/2015
1Trichloroethylene (Trichloroethene)IBA
12/2015
1Amiodarone (Amiodarona)FDA LinkGeneric
11/2015
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
11/2015
1SodiumIBA
09/2015
1Uricosuric AgentsIBA
03/2015
1Free RadicalsIBA
11/2014
1Interleukin-1 (Interleukin 1)IBA
03/2014
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
03/2014
1canakinumabFDA Link
03/2014
1TabletsIBA
03/2014
1rilonaceptFDA Link
03/2014
1Analgesics (Analgesic Drugs)IBA
09/2012
1Indomethacin (Indometacin)FDA LinkGeneric
09/2012
1Celecoxib (Celebrex)FDA Link
09/2012
1Losartan (Cozaar)FDA LinkGeneric
12/2011
1Fenofibrate (CiL)FDA LinkGeneric
12/2011
1Phosphates (Orthophosphate)IBA
08/2003
1Leflunomide (Arava)FDA LinkGeneric
08/2003
1benzbromarone drug combination allopurinolIBA
08/2002

Therapy/Procedure

19Therapeutics
01/2022 - 08/2002
2Drug Therapy (Chemotherapy)
12/2018 - 01/2018
1Biological Therapy
01/2019
1Bariatric Surgery
11/2017
1Aftercare (After-Treatment)
03/2017
1Ambulatory Care (Outpatient Care)
12/2012